Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Satellos Bioscience Inc Com V.ICO


Primary Symbol: ICOTF

iCo Therapeutics Inc is a Canada based biotechnology company. It is involved in the Research and development of ophthalmic indications. The company identifies, develops, and commercialize drug candidates with clinical history, and re-doses, reformulates and develops these drug candidates to treat sight and life-threatening diseases. Its in-licensed assets are iCo-008 and the Oral AmpB Delivery System. iCo-008 is a human monoclonal antibody targeting eotaxin-1 that acts as a messenger between...


GREY:ICOTF - Post by User

Post by GustKingon Jun 25, 2018 8:16pm
95 Views
Post# 28227223

Rae is up big

Rae is up bignot sure if we will see mr. rae selling his shares tomorrow or possibly wed. 
and it's likely that he is keeping his shares tight for something big.. 

I will be waiting and speculating tomorrow for any signs of selloffs or buy ins..

i would be comfy at 0.10c a share before any big news here.






May 23/18 May 23/18 Rae, Andrew Rae Direct Ownership Common Shares 10 - Acquisition in the public market 250,000 $0.035
May 23/18 May 22/18 Rae, Andrew Rae Direct Ownership Common Shares 10 - Acquisition in the public market 450,000 $0.035
May 23/18 May 18/18 Rae, Andrew Rae Direct Ownership Common Shares 10 - Acquisition in the public market 500,000 $0.035

<< Previous
Bullboard Posts
Next >>